Autonomix Medical wins European patent for eye-based neural activity assessment system
AMIX•Autonomix Medical won a European patent for systems that assess neural activity in the eye to gauge autonomic nervous system function.
1. Patent coverage
The patent covers ocular-based monitoring methods intended to support patient assessment, treatment guidance and procedural feedback. Autonomix said it strengthens the company’s intellectual property position in Europe for its precision neuromodulation platform.
